CNS Spectrums covers all aspects of the clinical neurosciences, neurotherapeutics, and neuropsychopharmacology, particularly those pertinent to the clinician and clinical investigator. The journal features focused, in-depth reviews, perspectives, and original research articles. New therapeutics of all types in psychiatry, mental health, and neurology are emphasized, especially first in man studies, proof of concept studies, and translational basic neuroscience studies. Subject coverage spans the full spectrum of neuropsychiatry, focusing on those crossing traditional boundaries between neurology and psychiatry.

Editorial board
Editor-in-Chief
Dr. Stephen M. Stahl
University of California San Diego, USA
Psychopharmacologic treatment of resistant cases; Neurology
Field Editors
Dr. Bernardo Dell'Osso
University of Milan, Italy 
Obsessive-compulsive related disorders, bipolar disorders, psychopharmacology and brain stimulation
Dr. Joseph F. Goldberg
Icahn School of Medicine at Mount Sinai, USA
Psychiatry; mood disorders, particularly bipolar disorder; psychopharmacology; brain imaging; creativity; psychiatric phenomenology
Dr. Donatella Marazziti
University of Pisa, Italy
Psychopharmacology, neurobiology, mood and anxiety disorders, OCD and related disorders, clinical psychiatry
Dr. Humberto Nicolini
National Institutes of Health, Minister of Health, Mexico
Specialties:  Obsessive compulsive disorder, molecular genotypes, neurodegenerative disorders, epidemiology
Dr. Stefano Pallanti
University of Florence, Italy
Treatment-resistant OCD, PANDAS, Anxiety in Psychosis, Anxiety Disorder in pregnancy, puerperium and postpartum, ADHD – OCD spectrum, Bipolar disorder, rTMS and Neuromodulation treatments
Dr. Thomas E. Schlaepfer
University of Bonn, Germany
Brain stimulation; deep brain stimulation; vagus nerve stimulation; repetitive transcranial magnetic stimulation; magnetic seizure therapy
Dr. Frank I. Tarazi
Harvard Medical School, USA
Alzheimer's Disease, schizophrenia, bipolar disorder, depression, ADHD, insomnia and Huntington's disease.
Dr. Carlos A. Zarate, Jr.
National Institute of Mental Health, USA
Major depressive disorders; bipolar disorder; mood disorders; proof-of-concept studies; glutamate
Deputy Editor
Dr. Thomas L. Schwartz
SUNY Upstate Medical University, USA
Psychopharmacology; clinical trial research experience in treatment-resistant depression; anxiety disorders; and psychosomatic illness
Editorial Board
Jagannadha Avasarala, University of South Carolina School of Medicine, USA
Leslie Citrome, New York Medical College, USA
Maria Conceição do Rosario, University of São Paulo Medical School, Brazil
Christoph U. Correll, Northwell Health, USA
Jeffrey L. Cummings, Cleveland Clinic, USA
Thilo Deckersbach, Harvard Medical School, USA
Koen Demyttenaere, University Psychiatric Center KuLeuven, Belgium
Nesrin Dilbaz, Üsküdar University NP Brain Hospital, Turkey
Karen D. Ersche, University of Cambridge, UK
Gianni Faedda, The Mood Disorders Center of New York, USA
Robert L. Findling, The Johns Hopkins Hospital, USA
Patrick R. Finley, The University of California, San Francisco, USA
Kostas N. Fountoulakis, Aristotle University of Thessaloniki, Greece
Mark S. George, Medical University of South Carolina, USA
Ira D. Glick, Stanford University, USA
Joseph F. Goldberg, Icahn School of Medicine at Mount Sinai, USA
Jon Grant, University of Chicago, USA
Gregor Hasler, University of Bern, Switzerland
Eric Hollander, Albert Einstein College of Medicine and Montefiore Medical Center, USA
Daphne Holt, Harvard Medical School, USA
Oliver Howes, King’s College London, UK
Peter B. Jones, University of Cambridge, UK
Andres M. Kanner, University of Miami, USA
Antony D. Loebel, New York University School of Medicine , USA
Donatella Marazziti, University of Pisa, Italy
Roger McIntyre, University of Toronto, Canada
Herbert Y. Meltzer, Northwestern University, USA
Philip Mitchell, University of New South Wales, Australia
Mary Moller, Pacific Lutheran University and Northwest Integrated Health, USA
Mark Muse, Muse Psychological Associates, USA
Humberto Nicolini, National Institutes of Health, Minister of Health, Mexico
Andrew A. Nierenberg, Harvard Medical School, USA
Stefano Pallanti, University of Florence, Italy
Katharine A. Phillips, Weill Cornell Medical College, USA
Diego A. Pizzagalli, Harvard Medical School, USA
Mark H. Pollack, Rush University Medical Center, USA
Mark H. Rapaport, Emory University, USA
Irismar Reis de Oliveira, Federal University of Bahia, Brazil
Trevor W. Robbins, University of Cambridge, UK
Peter P. Roy-Byrne, University of Washington School of Medicine, USA
Barbara J. Sahakian, University of Cambridge, UK
Gerard Sanacora, Yale University School of Medicine, USA
Alan F. Schatzberg, Stanford University School of Medicine, USA
Thomas E. Schlaepfer, University of Bonn, Germany
Thomas L. Schwartz, SUNY Upstate Medical University in Syracuse, USA
Erich Seifritz, University of Zürich, Switzerland
Jordan W. Smoller, Harvard Medical School, USA
Dan J. Stein, University of Cape Town (UCT), South Africa
Stephen Strakowski, University of Texas at Austin, USA
T. Scott Stroup, Columbia University, USA
Frank I. Tarazi, Harvard Medical School, USA
Michael E. Thase, University of Pennsylvania, USA
Michael Trimble, National Hospital for Neurology, Queen Square, London, UK
Madhukar H. Trivedi, University of Texas Southwestern Medical Center, USA
Hiroyuki Uchida, Keio University School of Medicine, Japan
Susan Velasquez, California Department of State Hospitals, USA
Karen Dineen Wagner, The University of Texas Medical Branch, USA
Katherine D. Warburton, California Department of State Hospitals, USA
Stephen R. Wisniewski, University of Pittsburgh, USA
Carlos A. Zarate, Jr., National Institute of Mental Health, USA
Joseph Zohar, Tel Aviv University, Israel
Managing Editor
Lisa Arrington, Cambridge University Press, USA